Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Distillers Company, historically a major Scotch whisky producer, expanded significantly into the pharmaceutical and chemical sectors during the mid-20th century. Through its subsidiary, Distillers Company (Biochemicals) Limited, it became one of the first large-scale manufacturers of penicillin in Europe and a prominent supplier of antibiotics. The company is most notably associated with the distribution of thalidomide (under the brand name Distaval) in the United Kingdom and the Commonwealth during the late 1950s and early 1960s. Following the thalidomide tragedy and subsequent litigation, the company's pharmaceutical interests were largely divested or absorbed. In 1986, The Distillers Company was acquired by Guinness, eventually becoming part of the global spirits giant Diageo.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Distillers.